BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23300236)

  • 1. Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women.
    Walker J; Fairley CK; Bradshaw CS; Tabrizi SN; Twin J; Chen MY; Taylor N; Donovan B; Kaldor JM; McNamee K; Urban E; Walker S; Currie M; Birden H; Bowden FJ; Gunn J; Pirotta M; Gurrin L; Harindra V; Garland SM; Hocking JS
    Clin Infect Dis; 2013 Apr; 56(8):1094-100. PubMed ID: 23300236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance.
    Jensen JS; Bradshaw CS; Tabrizi SN; Fairley CK; Hamasuna R
    Clin Infect Dis; 2008 Dec; 47(12):1546-53. PubMed ID: 18990060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of the A2058T macrolide resistance-associated mutation in Mycoplasma genitalium strains from the Netherlands.
    Braam JF; Slotboom B; Van Marm S; Severs TT; Van Maarseveen NM; Van Zwet T; Boel ECH; Berkhout H; Hagen F; Van De Bovenkamp JHB; Van Dommelen L; Kusters JG
    J Antimicrob Chemother; 2017 May; 72(5):1529-1530. PubMed ID: 28158595
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycoplasma genitalium, an emerging sexually transmitted pathogen.
    Cazanave C; Manhart LE; Bébéar C
    Med Mal Infect; 2012 Sep; 42(9):381-92. PubMed ID: 22975074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of macrolide resistance in Mycoplasma genitalium in France.
    Chrisment D; Charron A; Cazanave C; Pereyre S; Bébéar C
    J Antimicrob Chemother; 2012 Nov; 67(11):2598-601. PubMed ID: 22773740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.
    Couldwell DL; Tagg KA; Jeoffreys NJ; Gilbert GL
    Int J STD AIDS; 2013 Oct; 24(10):822-8. PubMed ID: 24052013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens.
    Bissessor M; Tabrizi SN; Twin J; Abdo H; Fairley CK; Chen MY; Vodstrcil LA; Jensen JS; Hocking JS; Garland SM; Bradshaw CS
    Clin Infect Dis; 2015 Apr; 60(8):1228-36. PubMed ID: 25537875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.
    Ke W; Li D; Tso LS; Wei R; Lan Y; Chen Z; Zhang X; Wang L; Liang C; Liao Y; Chen H; Liu Y; Zheng H; Yang L
    BMC Infect Dis; 2020 Dec; 20(1):950. PubMed ID: 33308173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis.
    Machalek DA; Tao Y; Shilling H; Jensen JS; Unemo M; Murray G; Chow EPF; Low N; Garland SM; Vodstrcil LA; Fairley CK; Hocking JS; Zhang L; Bradshaw CS
    Lancet Infect Dis; 2020 Nov; 20(11):1302-1314. PubMed ID: 32622378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycoplasma genitalium in the Far North Queensland backpacker population: An observational study of prevalence and azithromycin resistance.
    Trevis T; Gossé M; Santarossa N; Tabrizi S; Russell D; McBride WJ
    PLoS One; 2018; 13(8):e0202428. PubMed ID: 30153259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin.
    Ito S; Shimada Y; Yamaguchi Y; Yasuda M; Yokoi S; Ito S; Nakano M; Ishiko H; Deguchi T
    Sex Transm Infect; 2011 Aug; 87(5):412-4. PubMed ID: 21653933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium: Impact on Treatment Outcome and Resistance.
    Read TR; Fairley CK; Tabrizi SN; Bissessor M; Vodstrcil L; Chow EP; Grant M; Danielewski J; Garland SM; Hocking JS; Chen MY; Bradshaw CS
    Clin Infect Dis; 2017 Feb; 64(3):250-256. PubMed ID: 28011607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment.
    Nijhuis RH; Severs TT; Van der Vegt DS; Van Zwet AA; Kusters JG
    J Antimicrob Chemother; 2015 Sep; 70(9):2515-8. PubMed ID: 25995292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycoplasma genitalium and Macrolide Resistance-associated Mutations in the Skåne Region of Southern Sweden 2015.
    Forslund O; Hjelm M; El-Ali R; Johnsson A; Bjartling C
    Acta Derm Venereol; 2017 Nov; 97(10):1235-1238. PubMed ID: 28681067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women.
    Falk L; Enger M; Jensen JS
    J Antimicrob Chemother; 2015 Nov; 70(11):3134-40. PubMed ID: 26283670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin.
    Guschin A; Ryzhikh P; Rumyantseva T; Gomberg M; Unemo M
    BMC Infect Dis; 2015 Feb; 15():40. PubMed ID: 25645440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Mycoplasma genitalium and Azithromycin-resistant Infections Among Remnant Clinical Specimens, Los Angeles.
    Allan-Blitz LT; Mokany E; Campeau S; Wee R; Shannon C; Klausner JD
    Sex Transm Dis; 2018 Sep; 45(9):632-635. PubMed ID: 29509566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016.
    Unemo M; Salado-Rasmussen K; Hansen M; Olsen AO; Falk M; Golparian D; Aasterød M; Ringlander J; Nilsson CS; Sundqvist M; Schønning K; Moi H; Westh H; Jensen JS
    Clin Microbiol Infect; 2018 May; 24(5):533-539. PubMed ID: 28923377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycoplasma genitalium: An emergent sexually transmitted disease?
    Manhart LE
    Infect Dis Clin North Am; 2013 Dec; 27(4):779-92. PubMed ID: 24275270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g!
    Horner P; Blee K; Adams E
    Curr Opin Infect Dis; 2014 Feb; 27(1):68-74. PubMed ID: 24322592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.